JEREMY DALLEY: Open Payments
NPI 1306273552 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 35 payments from 10 companies in 2025. Trend: 2023 $261 · 2024 $466 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $335 |
| Arcutis Biotherapeutics, Inc. | 4 | $187 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| Incyte Corporation | 2 | $47 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $45 |
| GENZYME CORPORATION | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| UCB, Inc. | 1 | $29 |
| Organon LLC | 2 | $17 |
| LEO Pharma Inc. | 1 | $14 |
Products named: SKYRIZI, DUPIXENT, RINVOQ, Zoryve, OPZELURA, ILUMYA, Bimzelx, QULIPTA.
Industry payments across ID — which companies pay providers there.
